⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30977077 | 1.00 | — | — | |
| SCHEMBL27379560 | 1.00 | — | — | |
| SCHEMBL27379452 | 1.00 | — | — | |
| SCHEMBL24894703 | 1.00 | — | — | |
| SCHEMBL27379569 | 1.00 | — | — | |
| SCHEMBL24894685 | 1.00 | — | — | |
| SCHEMBL30977084 | 1.00 | — | — | |
| SCHEMBL24894683 | 1.00 | — | — | |
| SCHEMBL24894376 | 0.88 | — | — | |
| SCHEMBL24894511 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287100-A1 | ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS | SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) | 2024-08-29 | — | — | US | disclosed |
| WO-2024123102-A1 | NOVEL TRICYCLIC COMPOUND AS KRAS G12D INHIBITOR, AND USE THEREOF | 에스케이바이오팜 주식회사 | 2024-06-13 | — | — | WO | disclosed |
| WO-2024091409-A1 | TRICYCLIC DERIVATIVES AS KRAS INHIBITORS | NIKANG THERAPEUTICS, INC. (US) | 2024-05-02 | — | — | WO | disclosed |